GM-CSFR alpha Products

Description

Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID

1438

Alternate Names

CD116 antigen CD116 CDw116 colony stimulating factor 2 receptor alpha subunit colony stimulating factor 2 receptor, alpha, low-affinity(granulocyte-macrophage) CSF2R CSF2RA CSF2RAX CSF2RAY CSF2RX CSF2RY GM-CSF R alpha GM-CSF receptor alpha subunit GMCSFR alpha GMCSFR GM-CSFRa GM-CSF-R-alpha GMCSFR-alpha GMR GMR-alpha granulocyte-macrophage colony-stimulating factor receptor alpha chain granulocyte-macrophage colony-stimulating factor receptor subunit alpha MGC3848 MGC4838

Research Areas for GM-CSFR alpha

Find related products by research area and learn more about each of the different research areas below.

Cancer